Curriculum Vitae Frank Essmann
Affiliation
Group leader at the Dr. Margarete Fischer-Bosch – Institute of Clinical Pharmacology
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 5755
fax: ++49-711-859295
email: frank.essmann@ikp-stuttgart.de
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 5755
fax: ++49-711-859295
email: frank.essmann@ikp-stuttgart.de
PD Dr. Frank Essmann
phone: ++49-711-8101 5755
Professional Education and Career
1992-1997 | Studies in chemistry at the University of Dortmund, Germany |
1997 | Diploma thesis at the Max-Planck-Institute for Molecular Physiology and Diploma in chemistry |
1997-1999 | PhD thesis: “Mechanisms of Apoptosis in Cancer: Regulatory Role of Caspases” at the Charité / Humboldt University Berlin (Prof. P.T. Daniel) and Max-Delbrück-Centrum (MDC) (Prof. B. Wittmann-Liebold) |
1999-2001 | Post-doctoral scientist at the Charité / Humboldt University Berlin |
2001-2002 | Startup Co-Founder at Proteome Factory AG |
2002-2008 | Junior group leader at the Institute for Molecular Medicine / Heinrich Heine University Düsseldorf (Prof. K. Schulze-Osthoff) |
2008 | Habilitation in Molecular Medicine at the Heinrich Heine University Düsseldorf. „Regulationsebenen der Apoptose: Vom DNA-Schaden zur Proteinspaltung.“ |
2008-2018 | Group leader at the Dept of Molecular Medicine (Prof. K. Schulze-Osthoff) / Eberhard-Karls-University Tübingen, Germany |
Since 10/2018 | Group leader at the Dr. Margarete Fischer-Bosch – Institute of Clinical Pharmacology, Stuttgart, Germany |
Selected References
Major Projects
- tumor biology / signal transduction
- apoptosis / Bcl-2 protein family / mitochondria
- senescence / epigenetics
- immunology